Northrop earnings increased in the third quarter of 2026 as sales rose 7% to $11.1 billion and backlog reached a record $110 billion. The aerospace and defense company’s October 20 results announcement raised its full-year profit outlook, although quarterly operating margins declined from a year earlier. Diluted earnings per share increased 3% to $7.89 for the three months ended September 30.
Key Takeaways
- Net awards of $16.4 billion lifted backlog to $109.6 billion, rounded to $110 billion.
- Segment operating income rose 5%, but its margin fell to 12.1% from 12.3%.
- Management raised 2026 profit guidance and projected sales growth of 5%–7% in 2027.
Table of Contents
- Northrop earnings follow strong contract awards
- Higher profit did not translate into wider overall margins
- Annual profit guidance rises while cash targets hold
- 2027 outlook balances program growth with investment
- Conclusion
Northrop earnings follow strong contract awards
Northrop Grumman’s third-quarter 2026 earnings release put net awards at $16.4 billion, including $4.6 billion for restricted programs, $2.0 billion for Sentinel and $1.4 billion for Virginia Class submarines. The quarter’s book-to-bill ratio was 1.5 times, meaning new awards exceeded sales recognized during the period.
Backlog increased about 20% from a year earlier. Chief Executive Officer Kathy Warden said roughly 35% was expected to convert into sales over the next 12 months, with another 55% over the following 24 months. That provides visibility into future revenue, but the timing still depends on program execution and funding.
All four business segments recorded higher quarterly sales. Aeronautics Systems led with 14% growth, followed by Defense Systems at 12%; Mission Systems and Space Systems each grew 2%.
| Item | Details |
|---|---|
| 2026 sales guidance | $43.75 billion–$44.25 billion; unchanged. |
| 2026 segment operating income guidance | $4.94 billion–$5.04 billion; previously $4.85 billion–$5.00 billion. |
| 2026 MTM-adjusted EPS guidance | $29.35–$29.75; previously $28.60–$29.10. |
| 2026 adjusted free cash flow guidance | $3.1 billion–$3.5 billion; unchanged. |
Higher profit did not translate into wider overall margins
Segment operating income, a non-GAAP measure, increased to $1.345 billion from $1.277 billion. Its margin nevertheless declined by 20 basis points, partly because Mission Systems’ prior-year results included a favorable $68 million contract estimate adjustment in restricted advanced microelectronics.
Aeronautics Systems’ margin improved to 10.5% from 9.7%, supported by higher net contract margin adjustments. Space Systems’ margin rose to 11.3% from 11.0%. Those improvements contrasted with lower margins at Defense Systems and Mission Systems.
On a consolidated basis, operating income rose 2% to $1.269 billion, while operating margin fell to 11.4% from 11.9%. Net earnings increased 2% to $1.124 billion. A lower effective tax rate, principally reflecting higher research credits, supported the bottom line.
Annual profit guidance rises while cash targets hold
Northrop raised the midpoint of its 2026 segment operating income guidance by $65 million and its mark-to-market-adjusted earnings-per-share midpoint by $0.70. These are management forecasts and non-GAAP measures, distinct from the quarter’s reported diluted EPS. Full-year sales and adjusted free cash flow guidance were unchanged.
Quarterly adjusted free cash flow increased 44% to $1.810 billion. The gain included $371 million of proceeds from selling a B-21 test asset, alongside improved working capital. Operating cash flow rose a more modest 12% to $1.745 billion, showing that the asset sale accounted for a substantial part of the adjusted cash-flow increase.
Capital expenditures were $306 million in the quarter. Chief Financial Officer John Greene said fourth-quarter capital spending was expected to approach $1 billion as Northrop builds capacity for key programs.
2027 outlook balances program growth with investment
Management projected 2027 sales growth of 5%–7%, with segment operating income growing faster than sales and segment margin expanding by 10–20 basis points. It also forecast approximately $2.1 billion in capital expenditures and adjusted free cash flow of $3.3 billion–$3.7 billion.
Warden identified B-21, Sentinel, shipbuilding support and the expanding weapons portfolio as growth drivers. International sales, contract awards and the timing of government appropriations could affect where revenue lands within the range.
Execution risks remain. Warden said B-21 testing was reducing the risk of late discoveries, but acknowledged continuing risk on remaining fixed-price low-rate initial production units. Greene also cautioned that larger sales contributions from B-21 and Sentinel would pressure the margins of their respective segments.
The company’s guidance does not assume a prolonged government shutdown or the application of spending limits or other spending cuts.
Conclusion
The next scheduled checkpoint is the fourth-quarter earnings call, when management said it expects to narrow the 2027 sales-growth range. That update should clarify the balance between contract timing, production expansion and higher capital spending.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
